{
  "main_header": {
    "sid": 1003873,
    "name": "Vilin Bio Med",
    "stock_name": "Vilin Bio Med",
    "full_name": "Vilin Bio Med Ltd",
    "name_url": "stocks-analysis/vilin-bio-med",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "19.85",
    "chg": 0.9,
    "chgp": "4.75%",
    "dir": 1,
    "prev_price": "18.95",
    "mcapval": "26.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "VILINBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0L4V01013",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": 8000,
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vilin-bio-med-1003873-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Vilin Bio Med?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vilin-bio-med-3695750",
        "imagepath": "",
        "date": "2025-11-13 00:38:08",
        "description": "Answer:\nThe historical performance of Vilin Bio Med shows a fluctuating trend in key financial metrics over the past five years.\n\nBreakdown:\nVilin Bio Med's net sales have shown a general increase from INR 11.21 crore in March 2022 to INR 15.80 crore in March 2024, before slightly declining to INR 14.81 crore in March 2025. The total operating income followed a similar trend, peaking in March 2024. However, the raw material costs have risen significantly, from INR 9.06 crore in March 2021 to INR 13.47 crore in March 2025, impacting the operating profit, which decreased from INR 2.59 crore in March 2023 to INR 1.25 crore in March 2025. Profit before tax also declined from INR 1.78 crore in March 2023 to INR 0.31 crore in March 2025, while profit after tax dropped from INR 1.25 crore in March 2023 to INR 0.22 crore in March 2025. The company's total liabilities decreased from INR 32.40 crore in March 2024 to ..."
      },
      {
        "title": "Why is Vilin Bio Med falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vilin-bio-med-fallingrising-3645212",
        "imagepath": "",
        "date": "2025-10-25 00:09:11",
        "description": "As of 24-Oct, Vilin Bio Med Ltd's stock price is currently at 26.50, reflecting a decrease of 0.5, or 1.85%. The stock has underperformed its sector today by 1.46%, and while it is trading higher than its 20-day, 50-day, 100-day, and 200-day moving averages, it is lower than its 5-day moving average. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 16.67% compared to the 5-day average. Over the past week, the stock has decreased by 5.19%, although it has shown positive returns of 3.72% over the past month and 20.45% year-to-date.\n\nIn the broader market context, the Sensex has increased by 0.33% over the past week, indicating that the stock's short-term performance is lagging behind the benchmark. Despite a positive return of 3.72% over the last month, the stock's recent decline suggests that it is not keeping pace with the overall market trends. The l..."
      },
      {
        "title": "Why is Vilin Bio Med falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vilin-bio-med-fallingrising-3630280",
        "imagepath": "",
        "date": "2025-10-17 23:52:09",
        "description": "As of 17-Oct, Vilin Bio Med Ltd's stock price is rising, currently at 27.95, with an increase of 1.15, representing a 4.29% gain. The stock has shown strong performance, outperforming its sector by 3.82% today. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Over the past week, the stock has increased by 9.61%, and it has also performed well over the past month with an 11.58% rise. However, there has been a notable decline in investor participation, with delivery volume falling by 58.33% against the 5-day average, which could indicate a potential concern regarding sustained interest in the stock.\n\nIn the broader market context, Vilin Bio Med's short-term performance significantly outpaces the Sensex, which has only risen by 1.68% over the past week. This strong relative performance suggests that investor sentiment towards Vilin ..."
      },
      {
        "title": "Why is Vilin Bio Med falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vilin-bio-med-fallingrising-3568623",
        "imagepath": "",
        "date": "2025-09-24 23:38:29",
        "description": "As of 24-Sep, Vilin Bio Med Ltd's stock price is currently at 25.55, reflecting a slight increase of 0.05 or 0.2%. The stock has shown strong performance recently, with a 1-week return of 2.00% and a 1-month return of 4.07%. Additionally, it has outperformed the sector by 0.65% today. The stock is trading above its 5-day, 20-day, and 200-day moving averages, although it remains below the 50-day and 100-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 87.5% compared to the 5-day average, indicating growing interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nBroader market context shows that while Vilin Bio Med has performed well, the benchmark Sensex has declined by 1.08% over the past week, highlighting the stock's re..."
      },
      {
        "title": "Is Vilin Bio Med overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-vilin-bio-med-overvalued-or-undervalued-3563264",
        "imagepath": "",
        "date": "2025-09-24 08:06:24",
        "description": "As of 23 September 2025, the valuation grade for Vilin Bio Med has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued, with a PE ratio of 35.50, an EV to EBIT of 38.02, and a PEG ratio of 0.95. These metrics suggest that the stock is trading at a premium compared to its earnings growth potential.\n\nIn comparison to its peers, Vilin Bio Med's PE ratio is higher than Sun Pharma's 34.11 and significantly above Cipla's more attractive 22.93. Additionally, while Divi's Lab shows a very expensive valuation with a PE of 69.64, it highlights the disparity within the sector. Notably, Vilin Bio Med has outperformed the Sensex over the past year with a return of 41.27%, contrasting with the Sensex's decline of 2.97%. This performance, however, does not mitigate the concerns regarding its current valuation levels...."
      },
      {
        "title": "Why is Vilin Bio Med falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vilin-bio-med-fallingrising-3562593",
        "imagepath": "",
        "date": "2025-09-23 23:48:11",
        "description": "As of 23-Sep, Vilin Bio Med Ltd is experiencing a decline in its stock price, currently at 25.50, which reflects a decrease of 0.75 or 2.86%. The stock has underperformed its sector today by 2.51%, despite being higher than its 5-day, 20-day, and 200-day moving averages, but lower than its 50-day and 100-day moving averages. Over the past week, the stock has seen a slight decline of 1.16%, while it has performed positively over the past month with a return of 3.87%. Notably, there has been a rise in investor participation, with a delivery volume increase of 11.11% against the 5-day average, indicating some interest despite the current price drop. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's movement.\n\nIn the broader market context, the stock's recent performance has been weaker compared to the benchmark, as it has declined by 1.16% ..."
      },
      {
        "title": "Is Vilin Bio Med overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-vilin-bio-med-overvalued-or-undervalued-3556483",
        "imagepath": "",
        "date": "2025-09-23 08:05:42",
        "description": "As of 22 September 2025, the valuation grade for Vilin Bio Med has moved from very expensive to expensive, indicating a slight improvement in perceived value. The company is currently considered overvalued. Key ratios include a PE Ratio of 33.55, an EV to EBIT of 36.07, and a Price to Book Value of 1.45. \n\nIn comparison to peers, Sun Pharma has a PE Ratio of 34.24 and an EV to EBITDA of 23.18, while Cipla, considered attractive, has a PE Ratio of 23.1 and an EV to EBITDA of 16.26. Despite the recent stock performance showing a 45.43% return over the past year compared to a -2.28% return for the Sensex, the valuation metrics suggest that Vilin Bio Med remains overvalued in the current market context...."
      },
      {
        "title": "Why is Vilin Bio Med falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vilin-bio-med-fallingrising-3555828",
        "imagepath": "",
        "date": "2025-09-22 23:38:16",
        "description": "As of 22-Sep, Vilin Bio Med Ltd's stock price is rising, currently at 26.25, reflecting an increase of 1.2 or 4.79%. The stock has shown strong performance, outperforming its sector by 5.87% today. Over the past week, it has gained 1.74%, and in the last month, it has risen by 6.92%. Year-to-date, the stock has increased by 19.32%, and over the past year, it has surged by 45.43%. However, there is a noted decline in investor participation, with delivery volume dropping by 44.44% against the 5-day average, which could indicate a potential concern for future trading activity. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's movement.\n\nBroader Market Context: The stock's recent performance has significantly outpaced the benchmark Sensex, which has only increased by 0.53% over the past week and 1.34% over the past month. Year-to-date,..."
      },
      {
        "title": "Why is Vilin Bio Med falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vilin-bio-med-fallingrising-3540387",
        "imagepath": "",
        "date": "2025-09-19 23:33:40",
        "description": "As of 19-Sep, Vilin Bio Med Ltd's stock price is currently at 25.05, showing no change (0.00%). The stock has underperformed its sector by 0.27% today, and while it is above its 5-day, 20-day, and 200-day moving averages, it remains below its 50-day and 100-day moving averages. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 44.44% against the 5-day average. Over the past week, the stock has increased by 1.83%, but it has decreased by 1.76% over the past month. Year-to-date, it has performed well with a gain of 13.86%, and over the past year, it has risen significantly by 38.78%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nBroader market context indicates that the stock's short-term performance has outpaced the Sensex, which has increased by 0.85% ov..."
      }
    ],
    "total": 68,
    "sid": "1003873",
    "stock_news_url": "https://www.marketsmojo.com/news/vilin-bio-med-1003873"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Vilin Bio Med?

2025-11-13 00:38:08

Answer: The historical performance of Vilin Bio Med shows a fluctuating trend in key financial metrics over the past five years. Breakdown: Vilin Bio Med's net sales have shown a general increase from INR 11.21 crore in March 2022 to INR 15.80 crore in March 2024, before slightly declining to INR 14.81 crore in March 2025. The total operating income followed a similar trend, peaking in March 2024. However, the raw material costs have risen significantly, from INR 9.06 crore in March 2021 to INR 13.47 crore in March 2025, impacting the operating profit, which decreased from INR 2.59 crore in March 2023 to INR 1.25 crore in March 2025. Profit before tax also declined from INR 1.78 crore in March 2023 to INR 0.31 crore in March 2025, while profit after tax dropped from INR 1.25 crore in March 2023 to INR 0.22 crore in March 2025. The company's total liabilities decreased from INR 32.40 crore in March 2024 to ...

Read More

Why is Vilin Bio Med falling/rising?

2025-10-25 00:09:11

As of 24-Oct, Vilin Bio Med Ltd's stock price is currently at 26.50, reflecting a decrease of 0.5, or 1.85%. The stock has underperformed its sector today by 1.46%, and while it is trading higher than its 20-day, 50-day, 100-day, and 200-day moving averages, it is lower than its 5-day moving average. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 16.67% compared to the 5-day average. Over the past week, the stock has decreased by 5.19%, although it has shown positive returns of 3.72% over the past month and 20.45% year-to-date. In the broader market context, the Sensex has increased by 0.33% over the past week, indicating that the stock's short-term performance is lagging behind the benchmark. Despite a positive return of 3.72% over the last month, the stock's recent decline suggests that it is not keeping pace with the overall market trends. The l...

Read More

Why is Vilin Bio Med falling/rising?

2025-10-17 23:52:09

As of 17-Oct, Vilin Bio Med Ltd's stock price is rising, currently at 27.95, with an increase of 1.15, representing a 4.29% gain. The stock has shown strong performance, outperforming its sector by 3.82% today. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Over the past week, the stock has increased by 9.61%, and it has also performed well over the past month with an 11.58% rise. However, there has been a notable decline in investor participation, with delivery volume falling by 58.33% against the 5-day average, which could indicate a potential concern regarding sustained interest in the stock. In the broader market context, Vilin Bio Med's short-term performance significantly outpaces the Sensex, which has only risen by 1.68% over the past week. This strong relative performance suggests that investor sentiment towards Vilin ...

Read More

Why is Vilin Bio Med falling/rising?

2025-09-24 23:38:29

As of 24-Sep, Vilin Bio Med Ltd's stock price is currently at 25.55, reflecting a slight increase of 0.05 or 0.2%. The stock has shown strong performance recently, with a 1-week return of 2.00% and a 1-month return of 4.07%. Additionally, it has outperformed the sector by 0.65% today. The stock is trading above its 5-day, 20-day, and 200-day moving averages, although it remains below the 50-day and 100-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 87.5% compared to the 5-day average, indicating growing interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. Broader market context shows that while Vilin Bio Med has performed well, the benchmark Sensex has declined by 1.08% over the past week, highlighting the stock's re...

Read More

Is Vilin Bio Med overvalued or undervalued?

2025-09-24 08:06:24

As of 23 September 2025, the valuation grade for Vilin Bio Med has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued, with a PE ratio of 35.50, an EV to EBIT of 38.02, and a PEG ratio of 0.95. These metrics suggest that the stock is trading at a premium compared to its earnings growth potential. In comparison to its peers, Vilin Bio Med's PE ratio is higher than Sun Pharma's 34.11 and significantly above Cipla's more attractive 22.93. Additionally, while Divi's Lab shows a very expensive valuation with a PE of 69.64, it highlights the disparity within the sector. Notably, Vilin Bio Med has outperformed the Sensex over the past year with a return of 41.27%, contrasting with the Sensex's decline of 2.97%. This performance, however, does not mitigate the concerns regarding its current valuation levels....

Read More

Why is Vilin Bio Med falling/rising?

2025-09-23 23:48:11

As of 23-Sep, Vilin Bio Med Ltd is experiencing a decline in its stock price, currently at 25.50, which reflects a decrease of 0.75 or 2.86%. The stock has underperformed its sector today by 2.51%, despite being higher than its 5-day, 20-day, and 200-day moving averages, but lower than its 50-day and 100-day moving averages. Over the past week, the stock has seen a slight decline of 1.16%, while it has performed positively over the past month with a return of 3.87%. Notably, there has been a rise in investor participation, with a delivery volume increase of 11.11% against the 5-day average, indicating some interest despite the current price drop. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's movement. In the broader market context, the stock's recent performance has been weaker compared to the benchmark, as it has declined by 1.16% ...

Read More

Is Vilin Bio Med overvalued or undervalued?

2025-09-23 08:05:42

As of 22 September 2025, the valuation grade for Vilin Bio Med has moved from very expensive to expensive, indicating a slight improvement in perceived value. The company is currently considered overvalued. Key ratios include a PE Ratio of 33.55, an EV to EBIT of 36.07, and a Price to Book Value of 1.45. In comparison to peers, Sun Pharma has a PE Ratio of 34.24 and an EV to EBITDA of 23.18, while Cipla, considered attractive, has a PE Ratio of 23.1 and an EV to EBITDA of 16.26. Despite the recent stock performance showing a 45.43% return over the past year compared to a -2.28% return for the Sensex, the valuation metrics suggest that Vilin Bio Med remains overvalued in the current market context....

Read More

Why is Vilin Bio Med falling/rising?

2025-09-22 23:38:16

As of 22-Sep, Vilin Bio Med Ltd's stock price is rising, currently at 26.25, reflecting an increase of 1.2 or 4.79%. The stock has shown strong performance, outperforming its sector by 5.87% today. Over the past week, it has gained 1.74%, and in the last month, it has risen by 6.92%. Year-to-date, the stock has increased by 19.32%, and over the past year, it has surged by 45.43%. However, there is a noted decline in investor participation, with delivery volume dropping by 44.44% against the 5-day average, which could indicate a potential concern for future trading activity. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's movement. Broader Market Context: The stock's recent performance has significantly outpaced the benchmark Sensex, which has only increased by 0.53% over the past week and 1.34% over the past month. Year-to-date,...

Read More

Why is Vilin Bio Med falling/rising?

2025-09-19 23:33:40

As of 19-Sep, Vilin Bio Med Ltd's stock price is currently at 25.05, showing no change (0.00%). The stock has underperformed its sector by 0.27% today, and while it is above its 5-day, 20-day, and 200-day moving averages, it remains below its 50-day and 100-day moving averages. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 44.44% against the 5-day average. Over the past week, the stock has increased by 1.83%, but it has decreased by 1.76% over the past month. Year-to-date, it has performed well with a gain of 13.86%, and over the past year, it has risen significantly by 38.78%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. Broader market context indicates that the stock's short-term performance has outpaced the Sensex, which has increased by 0.85% ov...

Read More

View All News